Loading...

Pherecydes Pharma SA

ALPHE.PAEURONEXT
Healthcare
Biotechnology
2.00
-0.01(-0.50%)

Pherecydes Pharma SA (ALPHE.PA) Company Profile & Overview

Explore Pherecydes Pharma SA’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Pherecydes Pharma SA (ALPHE.PA) Company Profile & Overview

Pherecydes Pharma SA develops antibacterial treatments based on the use of bacteriophage viruses or phages. It develops a portfolio of therapeutics, such as anti-Staphylococcus aureusphages for the treatment of bone/joint and diabetic foot ulcer infections; anti-Pseudomonas aeruginosa phages for the treatment of complicated urinary tract infections; and anti-Escherichia coli phages for the treatment of respiratory tract infections. The company was founded in 2006 and is based in Romainville, France.

SectorHealthcare
IndustryBiotechnology
CEOThibaut du Fayet

Contact Information

33 1 48 40 65 35
102 avenue Gaston Roussel, Romainville, 93230

Company Facts

29 Employees
IPO DateFeb 5, 2021
CountryFR

Frequently Asked Questions

;